Ji Won Kim

Ji Won Kim

Auto-generated profile, based on publicly available information

Ji Won Kim

Department of Dermatology Seoul National University College of Medicine Seoul South Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SJSunhyae Jang
Sunhyae Jang
JOJungyoon Ohn
Jungyoon Ohn
JKJi Won Kim
Ji Won Kim
SKSo Min Kang
So Min Kang
DJDasom Jeon
Dasom Jeon
KKKyu Han Kim
Kyu Han Kim
The main factors involved in the pathogenesis of atopic dermatitis (AD) are skin barrier abnormality, allergy/immunology, and pruritus. Considering how oxidative stress influences these factors, antioxidant agents may be effective candidates in the treatment of AD. To evaluate the effect of Caffeoyl–Pro–His amide (CA-PH), an antioxidant agent, on 2,4-dinitrochlorobenzene (DNCB)-induced AD-like phenotypes in BALB/c mice. Topical sensitization and challenge by DNCB were performed on the dorsal skin of BALB/c mice to induce AD-like cutaneous lesions, phenotypes, and immunologic response. CA-PH was applied topically for 2 weeks to assess its effects on DNCB-induced AD-like phenotypes. As a result, CA-PH relieved DNCB-induced AD-like phenotypes quantified by dermatitis severity score, scratching duration, and trans-epidermal water loss. Histopathological analysis showed that CA-PH decreased epidermal thickening, the number of mast cells, and eosinophil infiltration in dermis. Immunohistochemical staining revealed that CA-PH recovered skin barrier-related proteins: filaggrin, involucrin, and loricrin. As for the immunologic aspects, CA-PH treatment lowered mRNA or protein levels of interleukin (IL)-4, IL-6, IL-17a, IL-1b, IL-31, and IL-33 levels and thymic stromal lymphopoietin (TSLP) levels in cutaneous tissue, reducing the DNCB-induced serum IgE level elevation. In conclusion, topical CA-PH may be a therapeutic option for the treatment of AD.

25 August 2021 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
JYJ. H. Yang
J. H. Yang
SCSoo Ick Cho
Soo Ick Cho
DLDong Hun Lee
Dong Hun Lee
JYJ. Y. Yoon
J. Y. Yoon
JMJ. Moon
J. Moon
DSDae Hun Suh
Dae Hun Suh

1 January 2019 in Annals of Dermatology
Verified
Journal Article
Open access
SCSoo Ick Cho
Soo Ick Cho
JKJi Won Kim
Ji Won Kim
GYGyeongyeon Yeo
Gyeongyeon Yeo
DCDongmuk Choi
Dongmuk Choi
JSJunggyo Seo
Junggyo Seo
JCJin Ho Chung
Jin Ho Chung